首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1419125

消融設備市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按設備、應用程式、最終用戶和地理位置

Ablation Device Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Device, Application, End-User, and Geography

出版日期: 2023年11月22日 | 出版商:

The Insight Partners | 英文 185 Pages | 商品交期: 1-5個工作天內

價格

簡介目錄

全球消融器械市場預計將從2022年的83.25億美元增加到2030年的160.20億美元。預計2022年至2030年該市場將以8.5%的CAGR成長。

推動市場成長的關鍵因素包括慢性病盛行率的上升、老年人口的增加以及對微創手術的需求不斷增加。然而，替代治療方法和療法的強勢地位阻礙了市場成長。

消融設備市場的市場促進因素

全球對微創手術的需求持續成長。與傳統開放性手術相比，微創手術有幾個優點，包括切口較小、恢復時間較短、疼痛減輕和併發症風險較低。先進技術用於微創治療，以識別和管理包括癌症在內的各種疾病。這些技術已被用來去除癌症腫瘤和淋巴結，且不會留下任何疤痕。外科醫生還可以使用微創手術採集組織進行活體組織切片和精確的分期測試。這使得外科醫生能夠設計出精確的癌症治療方案。

此外，根據加州大學舊金山分校放射與生物醫學影像系的說法，如果小腎腫瘤尚未擴散到腎臟之外，那麼腎腫瘤的微波消融（MWA）和射頻消融（RFA）是手術切除的實用替代方案。 MWA 和 RFA 是微創、非手術治療，恢復時間不到 24 小時。因此，消融裝置透過各種能量方式提供精確的組織破壞，在微創手術中發揮著至關重要的作用，從而推動了對消融裝置的需求。因此，對微創手術的需求推動了消融設備市場的成長。

阻礙消融設備市場的因素

消融技術面臨其他治療方法的競爭，包括手術介入、放射治療、全身性藥物治療和其他微創手術。根據所治療的特定病情，醫療保健提供者可能會根據療效、安全性、患者資格、成本效益或資源可用性等因素選擇替代治療方式。替代治療方案的可用性和偏好可能會限制消融裝置的採用和使用。例如，由於大眾對傳統癌症治療的認知較高，發展中國家對先進治療方案的採用率較低，以及外科醫生不願放棄傳統治療方案，因此手術、化療和放射治療等治療方法是癌症治療的首選方法。因此，上述因素阻礙了消融裝置市場的成長。

消融設備市場：細分概述

消融設備市場依設備分為射頻設備、雷射/光消融設備、超音波設備、冷凍消融設備等。射頻設備細分市場在 2022 年佔據更大的市場佔有率，預計該細分市場在 2022 年至 2030 年期間將實現更高的CAGR。射頻消融術是一種微創手術，用於治療肌瘤、骨骼、組織、甲狀腺、子宮內膜、靜脈曲張等。它是傳統外科手術的替代方案。

消融設備市場按應用細分為癌症治療、心血管疾病治療、眼科治療、婦科治療、泌尿科治療、美容外科等。 2022年，心血管疾病治療領域佔有更大的市場佔有率；此外，預計同一細分市場在 2022 年至 2030 年期間將出現更高的CAGR。

依最終用戶分類，消融設備市場分為醫院和診所、門診手術中心等。 2022年，醫院和診所細分市場佔據最大的市場佔有率，預計該細分市場在2022年至2030年期間複合CAGR最高。醫院和診所是消融設備的主要最終用戶，因為它們提供廣泛的醫療服務，包括需要消融的非侵入性手術。

消融設備市場：地理概況

據估計，2022 年至 2030 年亞太地區的CAGR最高。印度和中國等亞太國家擁有消融設備市場的巨大成長潛力。該地區的發展中國家改善了醫療基礎設施，增加了醫療支出，並越來越注重採用先進的醫療技術，為市場擴張提供了機會。隨著新興市場對醫療保健基礎設施的投資以及越來越多的醫生接觸先進的消融技術，對消融設備的需求將會增加，從而推動亞太地區的市場成長。

2022年，北美在全球消融設備市場規模中佔據最大佔有率。美國的癌症發生率很高，這推動了消融設備市場的成長。根據美國癌症協會估計，2021年有超過190萬人被診斷出罹患癌症，608,570人因癌症死亡。另據報導，在美國，有二分之一的男性和三分之一的女性在一生中會被診斷出罹患癌症。因此，美國癌症的高盛行率推動了消融設備市場的成長。

此外，根據美國醫療保險和醫療補助服務中心的數據，2021年美國國家醫療保健支出成長2.7%，達到4.3兆美元，即人均12,914美元。此外，醫療支出佔國內生產毛額的18.3%。此外，根據美國衛生與公眾服務部的數據，2019年至2028年，國家衛生支出預計將以每年平均5.4%的速度成長，到2028年預計將達到6.2兆美元。增加與藥物開發相關的研究的各種資金，刺激研究和學術機構對消融設備的需求。

A few of the major primary and secondary sources referred to while preparing the report on the ablation device market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (世界衛生組織).

歐洲
- 德國
- 法國
- 義大利
- 西班牙
- 英國
- 歐洲其他地區
亞太
- 澳洲
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地區

第 11 章：產業格局

併購
協議、合作、合資企業
新產品發布
擴張和其他策略發展

第 12 章：競爭格局

關鍵參與者的熱圖分析
公司定位與專注

第 13 章：消融設備市場 - 主要公司概況

Abbott

注意 - 將為以下公司列表提供類似資訊

美敦力
波士頓科學公司
康邁德公司
血管動力學
史密斯和侄子
奧林巴斯
Galil Medical Inc.（被 BTG International Ltd 收購）
Ethicon US, LLC（強生公司的子公司）
史賽克

第 14 章：附錄

詞彙表
關於 Insight Partners
市場情報雲

簡介目錄

Product Code: TIPRE00003095

The global ablation device market is expected to reach US$ 16.020 billion in 2030 from US$ 8.325 billion in 2022. The market is estimated to grow with a CAGR of 8.5% from 2022 to 2030.

The key factors driving the market's growth include the growing prevalence of chronic diseases, an increase in the geriatric population, and increasing demand for minimally invasive procedures. However, the strong position of alternative treatment methods and therapies hinders market growth.

Market Drivers of the Ablation Device Market

The demand for minimally invasive surgeries continues to rise globally. Minimally invasive procedures have several advantages over traditional open surgeries, including smaller incisions, shorter recovery time, reduced pain, and lower risk of complications. Advanced technology is used in minimally invasive treatments for the identification and management of a variety of disorders, including cancer. These techniques have been implemented to remove cancer tumors and lymph nodes without any scars. Surgeons can also use minimally invasive procedures to harvest tissues for biopsy and precise staging tests. This enables surgeons to devise precise cancer therapy programs.

Furthermore, according to the UCSF Department of Radiology & Biomedical Imaging, if the small renal tumors have not spread beyond the kidney, then microwave ablation (MWA) and radiofrequency ablation (RFA) of kidney tumors are practical alternatives to surgical resection. MWA and RFA are minimally invasive, non-surgical procedures with a recovery time of less than 24 hours. Thus, ablation devices play a crucial role in enabling minimally invasive surgeries by offering precise tissue destruction through various energy modalities, thereby driving the demand for ablation devices. Thus, the demand for minimally invasive surgeries fuels the ablation device market growth.

Factors Hampering the Ablation Device Market

ablation techniques face competition from alternative treatment methods, including surgical interventions, radiation therapy, systemic drug therapies, and other minimally invasive procedures. Depending on the specific condition being treated, healthcare providers may opt for alternative treatment modalities based on factors such as efficacy, safety profile, patient eligibility, cost-effectiveness, or availability of resources. The availability and preference for alternative treatment options can limit the adoption and utilization of ablation devices. For example, treatment methods such as surgery, chemotherapy, and radiation therapy are preferred in cancer treatment due to high public awareness of traditional cancer treatments, low adoption of advanced treatment options in developing countries, and surgeons' reluctance to abandon traditional treatment options. Thus, the factors mentioned hamper the growth of the ablation device market.

Ablation Device Market: Segmental Overview

The ablation device market, by device, is segmented into radiofrequency devices, laser/light ablation, ultrasound devices, cryoablation devices, and others. The radiofrequency devices segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR during 2022-2030. Radiofrequency ablation is a minimally invasive procedure used in the treatment of myomas, bones, tissues, thyroid, endometrium, varicose veins, and others. It is an alternative to the traditional surgical operation.

The ablation device market, by application, is segmented into cancer treatment, cardiovascular disease treatment, ophthalmologic treatment, gynecological treatment, urological treatment, cosmetic surgery, and others. The cardiovascular disease treatment segment held a larger market share in 2022; also, the same segment is anticipated to register a higher CAGR during 2022-2030.

The ablation device market, by end users, is segmented into hospitals and clinics, ambulatory surgical centers, and others. In 2022, the hospitals and clinics segment held the largest market share, and the same segment is anticipated to register the highest CAGR during 2022-2030. Hospitals and clinics are the primary end users of ablation devices as they offer a wide range of medical services, including non-invasive procedures that require ablation.

Ablation Device Market: Geographical Overview

Asia Pacific is estimated to register the highest CAGR during 2022-2030. Countries in the Asia Pacific, such as India and China, hold significant potential for the growth of the ablation devices market. Developing countries in the region with improving healthcare infrastructure, increasing healthcare expenditure, and a rising focus on adopting advanced medical technologies offer opportunities for market expansion. As emerging markets invest in healthcare infrastructure and as more physicians gain exposure to advanced ablation techniques, the demand for ablation devices will increase, boosting the market growth in Asia Pacific.

In 2022, North America held the largest share of the global ablation device market size. The US has a high prevalence of cancer cases, which propels the ablation device market growth. As per the American Cancer Society estimates, more than 1.9 million people were diagnosed with cancer in 2021, and 608,570 people died due to cancer. It is also reported that 1 in 2 men and 1 in 3 women will be diagnosed with cancer in their lifetime in the US. Thus, the high prevalence of cancer among people in the US fuels the ablation device market growth.

Furthermore, according to the US Centers for Medicare & Medicaid Services, the national healthcare expenditure in the US increased by 2.7 percent in 2021, reaching US$ 4.3 trillion or US$ 12,914 per person. Also, health spending accounted for 18.3 percent of the nation's Gross Domestic Product. Furthermore, according to the US Department of Health & Human Services, National health spending is expected to grow at a 5.4% annual rate from 2019 to 2028, and it is expected to reach US$ 6.2 trillion by 2028. The rising health expenditure is estimated to increase various funding in the research related to the development of drugs, fueling the demand for ablation device by research and academic institutes.

1. Introduction

1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness Analysis

3. Research Methodology

4. Ablation Device Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Ablation Device Market - Key Market Dynamics

5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints

6. Ablation Device Market - Global Market Analysis

6.1 Ablation Device - Global Market Overview
6.2 Ablation Device - Global Market and Forecast to 2030

7. Ablation Device Market - Revenue Analysis (USD Million) - By Product, 2020-2030

7.1 Overview
7.2 Laser/Light Devices
7.3 Radiofrequency Devices
7.4 Ultrasound Devices
7.5 Cryoablation Devices
7.6 Others

8. Ablation Device Market - Revenue Analysis (USD Million) - By Application, 2020-2030

8.1 Overview
8.2 Cancer Treatment
8.3 Cosmetic Surgery
8.4 Urological Treatment
8.5 Cardiovascular Treatment
8.6 Ophthalmologic Treatment
8.7 Gynecological Treatment
8.8 Others

9. Ablation Device Market - Revenue Analysis (USD Million) - By End Users, 2020-2030

9.1 Overview
9.2 Hospitals and Clinics
9.3 Ambulatory Surgical Centers (ASCs)
9.4 Others

10. Ablation Device Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

10.1 North America
- 10.1.1 North America Ablation Device Market Overview
- 10.1.2 North America Ablation Device Market Revenue and Forecasts to 2030
- 10.1.3 North America Ablation Device Market Revenue and Forecasts and Analysis - By Product
- 10.1.4 North America Ablation Device Market Revenue and Forecasts and Analysis - By Application
- 10.1.5 North America Ablation Device Market Revenue and Forecasts and Analysis - By End Users
- 10.1.6 North America Ablation Device Market Revenue and Forecasts and Analysis - By Countries
  - 10.1.6.1 United States Ablation Device Market
    - 10.1.6.1.1 United States Ablation Device Market, by Product
    - 10.1.6.1.2 United States Ablation Device Market, by Application
    - 10.1.6.1.3 United States Ablation Device Market, by End Users
  - 10.1.6.2 Canada Ablation Device Market
    - 10.1.6.2.1 Canada Ablation Device Market, by Product
    - 10.1.6.2.2 Canada Ablation Device Market, by Application
    - 10.1.6.2.3 Canada Ablation Device Market, by End Users
  - 10.1.6.3 Mexico Ablation Device Market
    - 10.1.6.3.1 Mexico Ablation Device Market, by Product
    - 10.1.6.3.2 Mexico Ablation Device Market, by Application
    - 10.1.6.3.3 Mexico Ablation Device Market, by End Users

Note - Similar analysis would be provided for below mentioned regions/countries

10.2 Europe
- 10.2.1 Germany
- 10.2.2 France
- 10.2.3 Italy
- 10.2.4 Spain
- 10.2.5 United Kingdom
- 10.2.6 Rest of Europe
10.3 Asia-Pacific
- 10.3.1 Australia
- 10.3.2 China
- 10.3.3 India
- 10.3.4 Japan
- 10.3.5 South Korea
- 10.3.6 Rest of Asia-Pacific
10.4 Middle East and Africa
- 10.4.1 South Africa
- 10.4.2 Saudi Arabia
- 10.4.3 U.A.E
- 10.4.4 Rest of Middle East and Africa
10.5 South and Central America
- 10.5.1 Brazil
- 10.5.2 Argentina
- 10.5.3 Rest of South and Central America

11. Industry Landscape

12.1 Mergers and Acquisitions
12.2 Agreements, Collaborations, Joint Ventures
12.3 New Product Launches
12.4 Expansions and Other Strategic Developments

12. Competitive Landscape

13.1 Heat Map Analysis by Key Players
13.2 Company Positioning and Concentration

13. Ablation Device Market - Key Company Profiles

14.1 Abbott
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments

Note - Similar information would be provided for below list of companies